Preliminary research show conolidine could inhibit particular ion channels, minimizing neuronal excitability and restricting ache indicators. This system is particularly relevant in neuropathic pain, where by abnormal signaling causes persistent distress. Moreover, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to